Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, today announces the appointment of clinical nephrology experts An De Vriese, ...

Trestle Biotherapeutics, Inc., today announced a research collaboration with Humacyte, Inc. (Nasdaq: HUMA), a ...

and when autologous vein graft is not feasible, and the final labeling removes any reference to synthetic graft material, which is better than expected, the analy Over the last 7 days, the United ...

Steroid therapy is the first-line treatment for graft-versus-host disease (GVHD). If GVHD does not respond to initial therapies, doctors may consider chemotherapy, monoclonal antibodies ...

That’s significantly more than watched The Talk—the daytime show Beyond The Gates replaced in CBS’ lineup—this same week last ...

The MAQUET line of FUSION grafts Graft merges ePTFE with PET, creating a completely new concept for peripheral vascular procedures. It delivers the easy handling of ePTFE with the reduced suture ...

HEMASHIELD PLATINUM Woven Double Velour Grafts are collagen-impregnated and come in straight, one-branch, or multi-branch graft configurations for aortic repair. Trusted for more than 20 years ...

Clinical trial data on hemodiafiltration (HDF) vs high-flux hemodialysis (HD) may not reflect its effectiveness in real-world patients. Expert opinion may fill the gap.

The increasing prevalence of neurological disorders, such as cerebral aneurysms, ischemic strokes, and arteriovenous malformations (AVMs), is the key factor fueling the demand for interventional ...